US2009178973A1PendingUtilityA1
System, Method and Apparatus for Purifying Biological Fluids Such as Blood and Constituents Thereof
Individually held — no corporate assignee on recordPriority: Sep 10, 2003Filed: Nov 26, 2008Published: Jul 16, 2009
Est. expirySep 10, 2023(expired)· nominal 20-yr term from priority
Inventors:Pierre Jean Messier
A61L 2/022A61L 2103/05A61M 1/3633A61M 1/3679A61M 1/0281A61M 1/3687A61M 1/342A61M 1/3437
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein is an innovative hemoperfusion system and method including a thermal-fused broad-spectrum biocidal iodinated interactive polymer for the treatment of biological contaminants in body fluids. In one exemplary embodiment, the system and method utilizes a Triosyn® thermal fused broad-spectrum iodinated interactive polymer, included in a hemoperfusion column, for devitalizing high levels of cell-free microorganisms in whole blood and biological fluids in relation with the characterization of blood cells viability and function post-treatment
Claims
exact text as granted — not AI-modified1 . A method for decontaminating blood, comprising:
a) providing a hemoperfusion unit containing a low-density chamber including an effective amount of demand disinfectant, said demand disinfectant being an iodinated resin; b) separating a unit of blood infected with a quantity of bacteria or viral particles to provide a red blood cell concentrate and a plasma concentrate; c) discarding the plasma concentrate; d) diluting the red blood cell concentrate with an aqueous solution; e) filtering said diluted red blood cell concentrate through said hemoperfusion unit at a selected flow rate,
wherein the amount of bacteria or viral particles is reduced by greater than 90%.
2 . The method of claim 1 , wherein the amount of bacteria or viral particles is reduced by greater than 95%.
3 . The method of claim 1 , wherein the amount of bacteria or viral particles is reduced by greater than 99%.
4 . The method of claim 1 , wherein the bacteria or viral particles are selected from the group consisting of Staphylococcus aureus, E. coli and MS2.
5 . The method of claim 1 further comprising gravity filtering red blood cell concentrate through a leukocyte filter to remove leukocytes prior to diluting the red blood cell concentrate.
6 . The method of claim 1 further comprising gravity filtering red blood cell concentrate through a leukocyte filter to remove leukocytes after diluting the red blood cell concentrate.
7 . The method of claim 1 , wherein the aqueous solution is a saline solution.
8 . The method of claim 1 , wherein the said flow rate is 50 ml/mm.
9 . The method of claim 1 , wherein the said flow rate is 20 ml/mm.
10 . The method of claim 1 , wherein the a low-density chamber further contains hydrodynamic diffusers.
11 . A method for decontaminating blood, comprising:
a) providing a hemoperfusion unit containing a low-density chamber including an effective amount of demand disinfectant, said demand disinfectant being an iodinated resin; b) sonicating a unit of blood infected with a quantity of bacteria or viral particles: c) separating the unit of blood to provide a red blood cell concentrate and a plasma concentrate; d) discarding the plasma concentrate; e) diluting the red blood, cell concentrate with an aqueous solution; f) filtering said diluted red blood cell concentrate through said hemoperfusion unit at a selected flow rate. wherein the amount of bacteria or viral particles is reduced by greater than 90%.
12 . A method of disinfecting red blood cells, comprising passing a unit of red blood cells infected with a quantity of bacteria or viral particles through a hemoperfusion unit containing a demand disinfectant iodinated resin, wherein the amount of bacteria or viral particles is reduced by greater than 90%.
13 . The method of claim 12 , wherein the hemoperfusion unit contains hydrodynamic diffusers that maximize contact time between said bacterial or viral particles and said demand disinfectant iodinated resin.
14 . The method as in claim 1 wherein said unit of whole blood is provided by a donor; said method further comprising: transfusing said red blood concentrate of step e) into said donor or a donee.
15 . A filtration method, comprising: providing a contaminated product having high concentrations of microorganisms; filtering said contaminated product with a hemoperfusion unit to remove said microorganisms; said hemoperfusion unit comprising: a low-density column including an effective amount of demand disinfectant; said disinfecting being an iodinated resin, wherein the concentration of microorganisms is reduced by greater than 90%.
16 . A portable hemoperfusion filtration system, comprising:
a) a plasma separator for removing plasma from whole blood to provide a red blood cell concentrate; b) a dilution device for diluting said red blood cell concentrate; c) a chamber containing a demand disinfectant, said demand disinfectant being an iodinated resin contained in said column; and d) a pump for moving said diluted red blood cell concentrate a blood constitute through said chamber column at a selected flow rate.
17 . The filtration system of claim 1 , wherein the chamber further contains hydrodynamic diffusers.
18 . A hemoperfusion filtration chamber comprising a demand disinfectant iodinated resin and a hydrodynamic diffuser, wherein the diffuser functions to increase the contact efficacy between the iodinated resin and bacteria in blood that is passed through said chamber.Join the waitlist — get patent alerts
Track US2009178973A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.